nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.101	0.314	CbGbCtD
Midazolam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0477	0.148	CbGbCtD
Midazolam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0322	0.0998	CbGbCtD
Midazolam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0307	0.0952	CbGbCtD
Midazolam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0274	0.0848	CbGbCtD
Midazolam—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0268	0.0831	CbGbCtD
Midazolam—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0253	0.0785	CbGbCtD
Midazolam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0161	0.0498	CbGbCtD
Midazolam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0152	0.047	CbGbCtD
Midazolam—UGT1A4—respiratory system—chronic obstructive pulmonary disease	0.0027	0.107	CbGeAlD
Midazolam—CYP4B1—respiratory system—chronic obstructive pulmonary disease	0.00266	0.105	CbGeAlD
Midazolam—CYP4B1—bronchus—chronic obstructive pulmonary disease	0.00219	0.0867	CbGeAlD
Midazolam—CYP4B1—trachea—chronic obstructive pulmonary disease	0.00197	0.0778	CbGeAlD
Midazolam—GABRP—respiratory system—chronic obstructive pulmonary disease	0.0015	0.0593	CbGeAlD
Midazolam—CYP4B1—lung—chronic obstructive pulmonary disease	0.00141	0.0559	CbGeAlD
Midazolam—Mazindol—SLC6A4—chronic obstructive pulmonary disease	0.00126	0.345	CrCbGaD
Midazolam—GABRP—bronchus—chronic obstructive pulmonary disease	0.00123	0.0488	CbGeAlD
Midazolam—GABRP—trachea—chronic obstructive pulmonary disease	0.00111	0.0438	CbGeAlD
Midazolam—GABRB3—respiratory system—chronic obstructive pulmonary disease	0.000969	0.0384	CbGeAlD
Midazolam—GABRE—bronchus—chronic obstructive pulmonary disease	0.000941	0.0373	CbGeAlD
Midazolam—GABRB3—connective tissue—chronic obstructive pulmonary disease	0.000853	0.0338	CbGeAlD
Midazolam—GABRE—trachea—chronic obstructive pulmonary disease	0.000845	0.0335	CbGeAlD
Midazolam—Delirium—Prednisone—chronic obstructive pulmonary disease	0.000834	0.00191	CcSEcCtD
Midazolam—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000834	0.00191	CcSEcCtD
Midazolam—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000833	0.00191	CcSEcCtD
Midazolam—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.000828	0.0019	CcSEcCtD
Midazolam—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000827	0.0019	CcSEcCtD
Midazolam—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000827	0.0019	CcSEcCtD
Midazolam—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000825	0.00189	CcSEcCtD
Midazolam—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000825	0.00189	CcSEcCtD
Midazolam—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000823	0.00189	CcSEcCtD
Midazolam—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000815	0.00187	CcSEcCtD
Midazolam—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00081	0.00186	CcSEcCtD
Midazolam—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000808	0.00185	CcSEcCtD
Midazolam—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000808	0.00185	CcSEcCtD
Midazolam—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000808	0.00185	CcSEcCtD
Midazolam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000803	0.00184	CcSEcCtD
Midazolam—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000803	0.00184	CcSEcCtD
Midazolam—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000802	0.00184	CcSEcCtD
Midazolam—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000802	0.00184	CcSEcCtD
Midazolam—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000799	0.00183	CcSEcCtD
Midazolam—GABRP—lung—chronic obstructive pulmonary disease	0.000795	0.0315	CbGeAlD
Midazolam—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000793	0.00182	CcSEcCtD
Midazolam—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000791	0.00181	CcSEcCtD
Midazolam—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000787	0.0018	CcSEcCtD
Midazolam—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000786	0.0018	CcSEcCtD
Midazolam—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000783	0.0018	CcSEcCtD
Midazolam—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000782	0.00179	CcSEcCtD
Midazolam—Tension—Formoterol—chronic obstructive pulmonary disease	0.000782	0.00179	CcSEcCtD
Midazolam—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000781	0.00179	CcSEcCtD
Midazolam—Injury—Prednisolone—chronic obstructive pulmonary disease	0.00078	0.00179	CcSEcCtD
Midazolam—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000779	0.00179	CcSEcCtD
Midazolam—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000776	0.00178	CcSEcCtD
Midazolam—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000774	0.00177	CcSEcCtD
Midazolam—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000774	0.00177	CcSEcCtD
Midazolam—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000761	0.00175	CcSEcCtD
Midazolam—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000758	0.00174	CcSEcCtD
Midazolam—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000757	0.00173	CcSEcCtD
Midazolam—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000753	0.00173	CcSEcCtD
Midazolam—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000747	0.00171	CcSEcCtD
Midazolam—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000747	0.00171	CcSEcCtD
Midazolam—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000741	0.0017	CcSEcCtD
Midazolam—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000739	0.00169	CcSEcCtD
Midazolam—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000733	0.00168	CcSEcCtD
Midazolam—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000733	0.00168	CcSEcCtD
Midazolam—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000732	0.00168	CcSEcCtD
Midazolam—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000731	0.00168	CcSEcCtD
Midazolam—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000724	0.00166	CcSEcCtD
Midazolam—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000718	0.00165	CcSEcCtD
Midazolam—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000718	0.00164	CcSEcCtD
Midazolam—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000717	0.00164	CcSEcCtD
Midazolam—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00071	0.00163	CcSEcCtD
Midazolam—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000706	0.00162	CcSEcCtD
Midazolam—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000705	0.00162	CcSEcCtD
Midazolam—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000696	0.0016	CcSEcCtD
Midazolam—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000696	0.00159	CcSEcCtD
Midazolam—Cough—Formoterol—chronic obstructive pulmonary disease	0.000696	0.00159	CcSEcCtD
Midazolam—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.00159	CcSEcCtD
Midazolam—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000689	0.00158	CcSEcCtD
Midazolam—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000685	0.00157	CcSEcCtD
Midazolam—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000682	0.00156	CcSEcCtD
Midazolam—Cough—Montelukast—chronic obstructive pulmonary disease	0.000681	0.00156	CcSEcCtD
Midazolam—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000679	0.00156	CcSEcCtD
Midazolam—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000679	0.00156	CcSEcCtD
Midazolam—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000676	0.00155	CcSEcCtD
Midazolam—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000676	0.00155	CcSEcCtD
Midazolam—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000676	0.00155	CcSEcCtD
Midazolam—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00155	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000674	0.00155	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000674	0.00155	CcSEcCtD
Midazolam—GABRB2—lung—chronic obstructive pulmonary disease	0.00067	0.0265	CbGeAlD
Midazolam—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000664	0.00152	CcSEcCtD
Midazolam—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000664	0.00152	CcSEcCtD
Midazolam—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000663	0.00152	CcSEcCtD
Midazolam—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000661	0.0262	CbGeAlD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00066	0.00151	CcSEcCtD
Midazolam—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000657	0.026	CbGeAlD
Midazolam—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000657	0.00151	CcSEcCtD
Midazolam—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000651	0.00149	CcSEcCtD
Midazolam—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000651	0.00149	CcSEcCtD
Midazolam—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00064	0.00147	CcSEcCtD
Midazolam—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000639	0.00146	CcSEcCtD
Midazolam—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000638	0.00146	CcSEcCtD
Midazolam—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000638	0.00146	CcSEcCtD
Midazolam—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000637	0.00146	CcSEcCtD
Midazolam—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000635	0.00146	CcSEcCtD
Midazolam—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000635	0.00146	CcSEcCtD
Midazolam—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000632	0.00145	CcSEcCtD
Midazolam—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000632	0.00145	CcSEcCtD
Midazolam—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000632	0.00145	CcSEcCtD
Midazolam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00063	0.00144	CcSEcCtD
Midazolam—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000627	0.00144	CcSEcCtD
Midazolam—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000626	0.00143	CcSEcCtD
Midazolam—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000625	0.00143	CcSEcCtD
Midazolam—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000619	0.00142	CcSEcCtD
Midazolam—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000617	0.00141	CcSEcCtD
Midazolam—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000617	0.0244	CbGeAlD
Midazolam—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000614	0.00141	CcSEcCtD
Midazolam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000608	0.00139	CcSEcCtD
Midazolam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000608	0.00139	CcSEcCtD
Midazolam—GABRE—lung—chronic obstructive pulmonary disease	0.000607	0.024	CbGeAlD
Midazolam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000605	0.00139	CcSEcCtD
Midazolam—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000604	0.00139	CcSEcCtD
Midazolam—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000602	0.00138	CcSEcCtD
Midazolam—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000602	0.00138	CcSEcCtD
Midazolam—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.0006	0.00137	CcSEcCtD
Midazolam—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.00137	CcSEcCtD
Midazolam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000594	0.00136	CcSEcCtD
Midazolam—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00058	0.00133	CcSEcCtD
Midazolam—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00058	0.00133	CcSEcCtD
Midazolam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000578	0.00133	CcSEcCtD
Midazolam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000578	0.00133	CcSEcCtD
Midazolam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000574	0.00132	CcSEcCtD
Midazolam—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000573	0.00131	CcSEcCtD
Midazolam—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000573	0.00131	CcSEcCtD
Midazolam—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000572	0.00131	CcSEcCtD
Midazolam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00057	0.00131	CcSEcCtD
Midazolam—Injury—Prednisone—chronic obstructive pulmonary disease	0.000567	0.0013	CcSEcCtD
Midazolam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000567	0.0013	CcSEcCtD
Midazolam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000565	0.0013	CcSEcCtD
Midazolam—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000562	0.00129	CcSEcCtD
Midazolam—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000562	0.00129	CcSEcCtD
Midazolam—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000561	0.00129	CcSEcCtD
Midazolam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000561	0.00129	CcSEcCtD
Midazolam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000561	0.00129	CcSEcCtD
Midazolam—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000556	0.00128	CcSEcCtD
Midazolam—Pain—Formoterol—chronic obstructive pulmonary disease	0.000556	0.00128	CcSEcCtD
Midazolam—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000556	0.00128	CcSEcCtD
Midazolam—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000556	0.00128	CcSEcCtD
Midazolam—Flunitrazepam—CYP1A2—chronic obstructive pulmonary disease	0.000553	0.151	CrCbGaD
Midazolam—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000552	0.00126	CcSEcCtD
Midazolam—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00055	0.00126	CcSEcCtD
Midazolam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000549	0.00126	CcSEcCtD
Midazolam—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00126	CcSEcCtD
Midazolam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000546	0.00125	CcSEcCtD
Midazolam—Pain—Montelukast—chronic obstructive pulmonary disease	0.000545	0.00125	CcSEcCtD
Midazolam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000544	0.00125	CcSEcCtD
Midazolam—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000542	0.00124	CcSEcCtD
Midazolam—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.00124	CcSEcCtD
Midazolam—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000541	0.0214	CbGeAlD
Midazolam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000539	0.00124	CcSEcCtD
Midazolam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000539	0.00123	CcSEcCtD
Midazolam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000536	0.00123	CcSEcCtD
Midazolam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000536	0.00123	CcSEcCtD
Midazolam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000536	0.00123	CcSEcCtD
Midazolam—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000534	0.00122	CcSEcCtD
Midazolam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000533	0.00122	CcSEcCtD
Midazolam—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000532	0.00122	CcSEcCtD
Midazolam—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00053	0.00122	CcSEcCtD
Midazolam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00053	0.00121	CcSEcCtD
Midazolam—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.0012	CcSEcCtD
Midazolam—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.0012	CcSEcCtD
Midazolam—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000521	0.00119	CcSEcCtD
Midazolam—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000517	0.00118	CcSEcCtD
Midazolam—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000517	0.00118	CcSEcCtD
Midazolam—GABRB3—lung—chronic obstructive pulmonary disease	0.000515	0.0204	CbGeAlD
Midazolam—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000513	0.00118	CcSEcCtD
Midazolam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000513	0.00118	CcSEcCtD
Midazolam—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000509	0.00117	CcSEcCtD
Midazolam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000508	0.00117	CcSEcCtD
Midazolam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000508	0.00116	CcSEcCtD
Midazolam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000508	0.00116	CcSEcCtD
Midazolam—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000506	0.00116	CcSEcCtD
Midazolam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.00116	CcSEcCtD
Midazolam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000505	0.00116	CcSEcCtD
Midazolam—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000505	0.00116	CcSEcCtD
Midazolam—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000497	0.00114	CcSEcCtD
Midazolam—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000495	0.00114	CcSEcCtD
Midazolam—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000494	0.00113	CcSEcCtD
Midazolam—Ketazolam—ALB—chronic obstructive pulmonary disease	0.000493	0.135	CrCbGaD
Midazolam—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000488	0.00112	CcSEcCtD
Midazolam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000479	0.0011	CcSEcCtD
Midazolam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000479	0.0011	CcSEcCtD
Midazolam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000479	0.0011	CcSEcCtD
Midazolam—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000478	0.0011	CcSEcCtD
Midazolam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00047	0.00108	CcSEcCtD
Midazolam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000467	0.00107	CcSEcCtD
Midazolam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000467	0.00107	CcSEcCtD
Midazolam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00046	0.00106	CcSEcCtD
Midazolam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00046	0.00106	CcSEcCtD
Midazolam—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000459	0.00105	CcSEcCtD
Midazolam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000457	0.00105	CcSEcCtD
Midazolam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00104	CcSEcCtD
Midazolam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000451	0.00103	CcSEcCtD
Midazolam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000441	0.00101	CcSEcCtD
Midazolam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.000996	CcSEcCtD
Midazolam—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000432	0.00099	CcSEcCtD
Midazolam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00043	0.000986	CcSEcCtD
Midazolam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00043	0.000986	CcSEcCtD
Midazolam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000421	0.000966	CcSEcCtD
Midazolam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000414	0.000948	CcSEcCtD
Midazolam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.000948	CcSEcCtD
Midazolam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.00094	CcSEcCtD
Midazolam—Rash—Formoterol—chronic obstructive pulmonary disease	0.00041	0.00094	CcSEcCtD
Midazolam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00041	0.00094	CcSEcCtD
Midazolam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.00094	CcSEcCtD
Midazolam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000408	0.000934	CcSEcCtD
Midazolam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.000934	CcSEcCtD
Midazolam—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000407	0.000933	CcSEcCtD
Midazolam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.000931	CcSEcCtD
Midazolam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000405	0.000929	CcSEcCtD
Midazolam—Rash—Montelukast—chronic obstructive pulmonary disease	0.000402	0.000921	CcSEcCtD
Midazolam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000401	0.00092	CcSEcCtD
Midazolam—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	0.000401	0.109	CrCbGaD
Midazolam—Depression—Prednisone—chronic obstructive pulmonary disease	0.0004	0.000918	CcSEcCtD
Midazolam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000399	0.000915	CcSEcCtD
Midazolam—Clonazepam—ALB—chronic obstructive pulmonary disease	0.000398	0.109	CrCbGaD
Midazolam—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000394	0.000902	CcSEcCtD
Midazolam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.000895	CcSEcCtD
Midazolam—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000388	0.000889	CcSEcCtD
Midazolam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000387	0.000888	CcSEcCtD
Midazolam—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000387	0.000888	CcSEcCtD
Midazolam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000387	0.000887	CcSEcCtD
Midazolam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000386	0.000886	CcSEcCtD
Midazolam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.000886	CcSEcCtD
Midazolam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.000882	CcSEcCtD
Midazolam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000379	0.000868	CcSEcCtD
Midazolam—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000367	0.000841	CcSEcCtD
Midazolam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.000837	CcSEcCtD
Midazolam—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000359	0.000822	CcSEcCtD
Midazolam—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000354	0.000812	CcSEcCtD
Midazolam—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.000353	0.0962	CrCbGaD
Midazolam—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000352	0.000808	CcSEcCtD
Midazolam—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000351	0.0139	CbGeAlD
Midazolam—CYP3A5—lung—chronic obstructive pulmonary disease	0.000351	0.0139	CbGeAlD
Midazolam—CYP2B6—lung—chronic obstructive pulmonary disease	0.000349	0.0138	CbGeAlD
Midazolam—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000347	0.000795	CcSEcCtD
Midazolam—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000344	0.000788	CcSEcCtD
Midazolam—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000772	CcSEcCtD
Midazolam—CYP2E1—lung—chronic obstructive pulmonary disease	0.000327	0.013	CbGeAlD
Midazolam—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000746	CcSEcCtD
Midazolam—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000316	0.000725	CcSEcCtD
Midazolam—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000316	0.000724	CcSEcCtD
Midazolam—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000314	0.000719	CcSEcCtD
Midazolam—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000301	0.000691	CcSEcCtD
Midazolam—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000296	0.000678	CcSEcCtD
Midazolam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.000666	CcSEcCtD
Midazolam—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000661	CcSEcCtD
Midazolam—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000282	0.000646	CcSEcCtD
Midazolam—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000281	0.000645	CcSEcCtD
Midazolam—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.000642	CcSEcCtD
Midazolam—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000266	0.00061	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000265	0.000608	CcSEcCtD
Midazolam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00026	0.000595	CcSEcCtD
Midazolam—ABCB1—trachea—chronic obstructive pulmonary disease	0.000259	0.0103	CbGeAlD
Midazolam—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000257	0.00121	CbGpPWpGaD
Midazolam—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000587	CcSEcCtD
Midazolam—Shock—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000577	CcSEcCtD
Midazolam—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000576	CcSEcCtD
Midazolam—CYP4B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00025	0.00118	CbGpPWpGaD
Midazolam—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000573	CcSEcCtD
Midazolam—SLC22A1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000249	0.00117	CbGpPWpGaD
Midazolam—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00057	CcSEcCtD
Midazolam—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000247	0.00117	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000245	0.00116	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000237	0.00112	CbGpPWpGaD
Midazolam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000233	0.000534	CcSEcCtD
Midazolam—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000527	CcSEcCtD
Midazolam—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000517	CcSEcCtD
Midazolam—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.000509	CcSEcCtD
Midazolam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.000509	CcSEcCtD
Midazolam—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000506	CcSEcCtD
Midazolam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000506	CcSEcCtD
Midazolam—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000502	CcSEcCtD
Midazolam—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00103	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000216	0.00102	CbGpPWpGaD
Midazolam—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000214	0.00101	CbGpPWpGaD
Midazolam—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.00101	CbGpPWpGaD
Midazolam—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000213	0.001	CbGpPWpGaD
Midazolam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000484	CcSEcCtD
Midazolam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00048	CcSEcCtD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000208	0.000983	CbGpPWpGaD
Midazolam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000208	0.000983	CbGpPWpGaD
Midazolam—Diazepam—ALB—chronic obstructive pulmonary disease	0.000204	0.0556	CrCbGaD
Midazolam—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000466	CcSEcCtD
Midazolam—SLC22A1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000203	0.000957	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000199	0.00094	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000196	0.000926	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000195	0.000917	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000192	0.000906	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00019	0.000895	CbGpPWpGaD
Midazolam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000432	CcSEcCtD
Midazolam—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000188	0.000887	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000188	0.000885	CbGpPWpGaD
Midazolam—ABCB1—lung—chronic obstructive pulmonary disease	0.000186	0.00738	CbGeAlD
Midazolam—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000186	0.000877	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000186	0.000875	CbGpPWpGaD
Midazolam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000421	CcSEcCtD
Midazolam—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000415	CcSEcCtD
Midazolam—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00018	0.00085	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00018	0.000849	CbGpPWpGaD
Midazolam—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000178	0.000837	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000173	0.000816	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000172	0.000813	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000172	0.000812	CbGpPWpGaD
Midazolam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000388	CcSEcCtD
Midazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.000794	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GC—chronic obstructive pulmonary disease	0.000168	0.000794	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000168	0.000793	CbGpPWpGaD
Midazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.000784	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000165	0.00078	CbGpPWpGaD
Midazolam—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000163	0.000769	CbGpPWpGaD
Midazolam—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000373	CcSEcCtD
Midazolam—Rash—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00037	CcSEcCtD
Midazolam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00037	CcSEcCtD
Midazolam—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000161	0.000758	CbGpPWpGaD
Midazolam—Headache—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000368	CcSEcCtD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.00016	0.000753	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00016	0.000753	CbGpPWpGaD
Midazolam—UGT1A4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000159	0.000751	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.000742	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00074	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000156	0.000738	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.000737	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.000736	CbGpPWpGaD
Midazolam—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.000729	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.000727	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.000726	CbGpPWpGaD
Midazolam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000349	CcSEcCtD
Midazolam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.000714	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000149	0.000702	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000147	0.000693	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000145	0.000685	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.000644	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000135	0.000639	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000133	0.000629	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000133	0.000628	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000133	0.000625	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000131	0.000619	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00013	0.000615	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00013	0.000614	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000129	0.000607	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000128	0.000605	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000127	0.0006	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000127	0.0006	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000126	0.000595	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000125	0.000591	CbGpPWpGaD
Midazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.000577	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000122	0.000577	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.000576	CbGpPWpGaD
Midazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00057	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000121	0.000569	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00012	0.000565	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00012	0.000564	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000118	0.000557	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000118	0.000556	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000117	0.000554	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.000547	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.000539	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.000536	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.000535	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.000528	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.000527	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000106	0.000502	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000105	0.000494	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000103	0.000487	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000102	0.000481	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000102	0.00048	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.0001	0.000474	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.92e-05	0.000468	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.76e-05	0.000461	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.64e-05	0.000455	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.36e-05	0.000442	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	9.33e-05	0.00044	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.19e-05	0.000434	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	9.19e-05	0.000434	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	9.14e-05	0.000431	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	9.12e-05	0.00043	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.09e-05	0.000429	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.87e-05	0.000419	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	8.82e-05	0.000416	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.82e-05	0.000416	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.73e-05	0.000412	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	8.64e-05	0.000407	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.63e-05	0.000407	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.62e-05	0.000407	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.57e-05	0.000404	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.41e-05	0.000397	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.36e-05	0.000394	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.29e-05	0.000391	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.27e-05	0.00039	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.21e-05	0.000387	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	8.13e-05	0.000383	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.06e-05	0.00038	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.01e-05	0.000378	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.78e-05	0.000367	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.64e-05	0.00036	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.64e-05	0.00036	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.64e-05	0.00036	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	7.57e-05	0.000357	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.56e-05	0.000356	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	7.47e-05	0.000352	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.4e-05	0.000349	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.25e-05	0.000342	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.15e-05	0.000337	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.13e-05	0.000336	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.05e-05	0.000332	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.03e-05	0.000332	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	6.88e-05	0.000325	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	6.85e-05	0.000323	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.4e-05	0.000302	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.37e-05	0.000301	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.29e-05	0.000297	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.29e-05	0.000296	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.2e-05	0.000292	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.18e-05	0.000292	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.05e-05	0.000286	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.05e-05	0.000285	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.04e-05	0.000285	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ALB—chronic obstructive pulmonary disease	6.03e-05	0.000285	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.03e-05	0.000285	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	6.01e-05	0.000284	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.97e-05	0.000282	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.97e-05	0.000281	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	5.89e-05	0.000278	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	5.88e-05	0.000277	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.86e-05	0.000277	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.86e-05	0.000276	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.79e-05	0.000273	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.77e-05	0.000272	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.59e-05	0.000264	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.56e-05	0.000262	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.55e-05	0.000262	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.48e-05	0.000259	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.47e-05	0.000258	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.46e-05	0.000258	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.29e-05	0.00025	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.27e-05	0.000249	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.2e-05	0.000245	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.14e-05	0.000243	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.05e-05	0.000238	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.96e-05	0.000234	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.93e-05	0.000233	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.84e-05	0.000228	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.56e-05	0.000215	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.44e-05	0.000209	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.43e-05	0.000209	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	4.39e-05	0.000207	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.24e-05	0.0002	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.23e-05	0.0002	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.13e-05	0.000195	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.12e-05	0.000194	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.09e-05	0.000193	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	4.01e-05	0.000189	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.77e-05	0.000178	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.73e-05	0.000176	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.69e-05	0.000174	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.68e-05	0.000174	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.62e-05	0.000171	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.61e-05	0.00017	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.54e-05	0.000167	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.43e-05	0.000162	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.38e-05	0.00016	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.32e-05	0.000156	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.28e-05	0.000155	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.25e-05	0.000153	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.22e-05	0.000152	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.21e-05	0.000151	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.18e-05	0.00015	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.17e-05	0.00015	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.16e-05	0.000149	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.08e-05	0.000145	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.04e-05	0.000143	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.96e-05	0.00014	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.9e-05	0.000137	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.9e-05	0.000137	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.86e-05	0.000135	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.83e-05	0.000133	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.83e-05	0.000133	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.81e-05	0.000132	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.78e-05	0.000131	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.73e-05	0.000129	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.73e-05	0.000129	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.68e-05	0.000126	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.67e-05	0.000126	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.67e-05	0.000126	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.63e-05	0.000124	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.54e-05	0.00012	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.5e-05	0.000118	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.42e-05	0.000114	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.39e-05	0.000113	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.28e-05	0.000107	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.25e-05	0.000106	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.23e-05	0.000105	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.23e-05	0.000105	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.2e-05	0.000104	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.19e-05	0.000104	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.19e-05	0.000103	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.12e-05	0.0001	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.09e-05	9.87e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.05e-05	9.66e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.04e-05	9.64e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.01e-05	9.5e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.98e-05	9.35e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.94e-05	9.16e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.94e-05	9.14e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.82e-05	8.6e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.74e-05	8.22e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.7e-05	8e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.68e-05	7.92e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.66e-05	7.81e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.62e-05	7.65e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.54e-05	7.28e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.49e-05	7.04e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.48e-05	6.96e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.46e-05	6.9e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	1.35e-05	6.36e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.35e-05	6.35e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.32e-05	6.23e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.32e-05	6.22e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.29e-05	6.08e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.26e-05	5.96e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.26e-05	5.94e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	5.85e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	4.88e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-05	4.81e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	9.94e-06	4.69e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.51e-06	4.49e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.51e-06	4.48e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.01e-06	4.25e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.13e-06	2.89e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.86e-06	2.76e-05	CbGpPWpGaD
